Company / Operating Income per Share
Sonoma Pharmaceuticals, Inc. Operating Income per Share History
FY2017-FY2026 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$2.27
FY2026
5-year range
-$6.02 / -$0.93
FY2022-FY2026
Trend
+62.3%
vs FY2025
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income per Share has fluctuated over the past 10 years, ranging from $-20.69 in FY2019 to $-0.93 in FY2024.
Based on SEC 10-K filings.
-2.27 in FY2026.
Declined from $-0.93 to $-2.27 over the past 2 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2026, operating income per share increased 62.3% year-over-year.
- Peak operating income per share was recorded in FY2024.
- Lowest operating income per share in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2026 | -$2.27 | +62.3% |
| FY2025 | -$6.02 | -550.3% |
| FY2024 | -$0.93 | +51.2% |
| FY2023 | -$1.90 | -15.2% |
| FY2022 | -$1.65 | +60.4% |
| FY2021 | -$4.16 | +51.4% |
| FY2020 | -$8.55 | +58.7% |
| FY2019 | -$20.69 | -584.1% |
| FY2018 | -$3.02 | +13.7% |
| FY2017 | -$3.51 | -692.1% |
As of FY2026 · SEC 10-K · Updated Jun 28, 2026